Market Timing with TurnerTrends Provides Great Stock Picks for the Sophisticated Investor   Timing the Market well requires Stock Picks that work

TurnerTrends Stock Rating Report for VNDA

Ticker: 
Data valid for week beginning August 30, 2010

Ticker Company Name
VNDA   [News] Vanda Pharmaceuticals Inc
Company Profile
"Vanda Pharmaceuticals Inc. (Vanda) is a biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders. Its product portfolio includes Fanapt (iloperidone), a compound for the treatment of schizophrenia, and Tasimelteon is a compound for the treatment of sleep and mood disorders, including Circadian Rhythm Sleep Disorders (CRSD)."

Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
Technical Chart (3 year) Sector Chart Industry Chart

VNDA Technical Chart

We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for VNDA. However, we only show it to our subscribers.

We update our ratings and stop losses EVERY WEEK.

Don't miss out on what we recommend for Vanda Pharmaceuticals Inc next week. Sign up today and start making money!

FREE TRIAL!!


Stock Information
Friday's Close $6.44
Volume Avg. 354204 shares
Industry Biotechnology and Drugs
Sector Healthcare
Our Stop Loss Members Only
Expected Move Members Only
Optionable? Yes

Stock Financials
Profit Margin .00%
Operating Margin -38.30%
Debt-to-Equity .00%
P/E ttm 0.00
EPS ttm $-0.560
Total Revenue $25,260,000
Market Cap $180,320
Annual Dividend $.00
Yield .000%
ROE 0.00%
Revenue Growth Rate Quarterly 0.00%
Earnings Growth Rate Quarterly 110.30%
Earnings Growth Rate Yearly 0.00%
Multi-Year Average Revenue Growth Rate 166.23%
Multi-Year Average Earnings Growth Rate N/A
Institutional Ownership Members Only
Value Rating Members Only
TurnerTrends Score  (Range: 0 to 200) Members Only


Latest News

Fri, 27 Aug 2010 18:56:10 GMTHelping Blind Patients To Sleep
Fri, 27 Aug 2010 14:33:01 GMTVanda's Pipeline Progresses
Thu, 26 Aug 2010 20:00:00 GMTVanda Pharmaceuticals Initiates Phase III Clinical Study Aimed at Resetting the Body Clock
Thu, 26 Aug 2010 17:24:04 GMTThese Are the Top 10 Pharma Underperform Calls
Wed, 25 Aug 2010 20:59:17 GMTFive Potential Small Cap Biotech Bargains
Fri, 20 Aug 2010 12:53:15 GMTBiotech Stock Mailbag: Avanir Pharma
Fri, 13 Aug 2010 11:00:00 GMTBiotech Stock Mailbag - 2Q Updates
Thu, 12 Aug 2010 17:05:48 GMTVANDA PHARMACEUTICALS INC. Financials
Thu, 12 Aug 2010 16:05:06 GMTHuman Capital: People on the move, Aug. 12
Fri, 06 Aug 2010 16:01:08 GMTVANDA PHARMACEUTICALS INC. Files SEC form 10-Q, Quarterly Report
Thu, 05 Aug 2010 21:13:07 GMTPenwest: Change Is Coming
Thu, 05 Aug 2010 15:05:06 GMTVanda Pharmaceuticals posts profits again
Thu, 05 Aug 2010 14:00:00 GMTVanda Pharmaceuticals Inc. Earnings Call scheduled for 10:00 am ET today
Thu, 05 Aug 2010 13:07:44 GMTVANDA PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
Thu, 05 Aug 2010 11:07:28 GMTQ2 2010 Vanda Pharmaceuticals Inc. Earnings Release - Before Market Open
Thu, 05 Aug 2010 10:30:00 GMTVanda Pharmaceuticals Reports Second Quarter 2010 Results
Mon, 02 Aug 2010 21:34:00 GMTVanda Pharmaceuticals to Announce Second Quarter 2010 Financial Results on August 5, 2010
Fri, 09 Jul 2010 20:16:38 GMTVANDA PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers
Thu, 01 Jul 2010 12:02:58 GMTVanda names former acting surgeon general to board
Thu, 01 Jul 2010 12:00:12 GMTVANDA PHARMACEUTICALS INC. Files SEC form 8-K, Change in Directors or Principal Officers
News provided by Yahoo! Finance
Home | Stock Ratings | Top 100 Stocks | New Hot Stock Picks | Sector Analyzer | Industry Analyzer | Member's Area | Articles | FAQ | Contact Us | Terms of Use | Advertise
(C) Copyright TurnerTrends, Inc.  All Rights Reserved.

*Past performance does not guarantee future results. TurnerTrends makes no representations or warrants that just because a stock would have made a profit in the past, using TurnerTrends buy recommendations or sell recommendations, it will make any profits in the future. It is possible that these same stocks will lose money in the future using the TurnerTrends stock recommendations.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither TurnerTrends nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the TurnerTrends site, a user agrees not to redistribute the information found therein.

thinkorswim, Division of TD AMERITRADE, Inc. and TurnerTrends are separate, unaffiliated companies and are not responsible for each other's services and products.